PMC:7048180 / 268-590 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T2","span":{"begin":20,"end":30},"obj":"Disease"},{"id":"T3","span":{"begin":259,"end":267},"obj":"Disease"}],"attributes":[{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"ory-confirmed human infections, including 259 deaths, posing a serious threat to human health. Currently, however, there is no specific antiviral treatment or vaccine. Considering the relatively high identity of receptor-binding domain (RBD) in 2019-nCoV and SARS-CoV, it is urgent to assess the cross-reactivity of anti-S"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T4","span":{"begin":14,"end":19},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T5","span":{"begin":61,"end":62},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T6","span":{"begin":81,"end":86},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"}],"text":"ory-confirmed human infections, including 259 deaths, posing a serious threat to human health. Currently, however, there is no specific antiviral treatment or vaccine. Considering the relatively high identity of receptor-binding domain (RBD) in 2019-nCoV and SARS-CoV, it is urgent to assess the cross-reactivity of anti-S"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T2","span":{"begin":136,"end":145},"obj":"Chemical"}],"attributes":[{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"}],"text":"ory-confirmed human infections, including 259 deaths, posing a serious threat to human health. Currently, however, there is no specific antiviral treatment or vaccine. Considering the relatively high identity of receptor-binding domain (RBD) in 2019-nCoV and SARS-CoV, it is urgent to assess the cross-reactivity of anti-S"}

{"project":"LitCovid-sentences","denotations":[{"id":"T8","span":{"begin":95,"end":167},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ory-confirmed human infections, including 259 deaths, posing a serious threat to human health. Currently, however, there is no specific antiviral treatment or vaccine. Considering the relatively high identity of receptor-binding domain (RBD) in 2019-nCoV and SARS-CoV, it is urgent to assess the cross-reactivity of anti-S"}

{"project":"LitCovid-PubTator","denotations":[{"id":"38","span":{"begin":14,"end":19},"obj":"Species"},{"id":"39","span":{"begin":81,"end":86},"obj":"Species"},{"id":"40","span":{"begin":245,"end":254},"obj":"Species"},{"id":"41","span":{"begin":259,"end":267},"obj":"Species"},{"id":"59","span":{"begin":20,"end":30},"obj":"Disease"},{"id":"60","span":{"begin":46,"end":52},"obj":"Disease"}],"attributes":[{"id":"A38","pred":"tao:has_database_id","subj":"38","obj":"Tax:9606"},{"id":"A39","pred":"tao:has_database_id","subj":"39","obj":"Tax:9606"},{"id":"A40","pred":"tao:has_database_id","subj":"40","obj":"Tax:2697049"},{"id":"A41","pred":"tao:has_database_id","subj":"41","obj":"Tax:694009"},{"id":"A59","pred":"tao:has_database_id","subj":"59","obj":"MESH:D007239"},{"id":"A60","pred":"tao:has_database_id","subj":"60","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ory-confirmed human infections, including 259 deaths, posing a serious threat to human health. Currently, however, there is no specific antiviral treatment or vaccine. Considering the relatively high identity of receptor-binding domain (RBD) in 2019-nCoV and SARS-CoV, it is urgent to assess the cross-reactivity of anti-S"}